Some TB patients still required to take pills in front of witnesses

Some TB patients still required to take pills in front of witnesses

Some tuberculosis patients in South Africa are still required to take their pills in front of a healthcare worker or family member. Is this a justified means of ensuring people take their medicine, or is it an invasion of personal autonomy? Elri Voigt asked local TB experts.

Read More

COVID-19: SA doctors were ready for multi-system inflammatory syndrome in children

COVID-19: SA doctors were ready for multi-system inflammatory syndrome in children

The South African National Institute for Communicable Diseases on Tuesday declared multi-system inflammatory syndrome in children (MIS-C) a Notifiable Medical Condition. Elna Schütz spoke with doctors who have been treating this rare and dangerous condition.

Read More

Opinion: Release of SA’s first National TB Prevalence Survey should not be delayed any longer

Opinion: Release of SA’s first National TB Prevalence Survey should not be delayed any longer

Even though it has been ready for months, findings of a critically important tuberculosis survey have not been made public. Every day that passes, the more outdated the findings become, and accordingly the less useful.

Read More

IN-DEPTH: The tangled web of medical device regulation in SA

IN-DEPTH: The tangled web of medical device regulation in SA

South Africa does not currently register medical devices. So what does it mean when the regulator announces that a new COVID-19 test or ventilator has been authorised? Catherine Tomlinson unpacks what is required to market a medical device in South Africa.

Read More

Drop in DR-TB detection points to “crisis” in SA’s TB response

Drop in DR-TB detection points to “crisis” in SA’s TB response

A leading TB doctor says that “it is no exaggeration to say there is a TB crisis in the country”, and that “the impact of this crisis could be even more devastating than COVID-19”. Kathryn Cleary explores the COVID-19 pandemic’s impact on South Africa’s TB response and the way forward.

Read More

1.3m switched to new ARV, but weight gain is a concern

1.3m switched to new ARV, but weight gain is a concern

Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.

Read More

Libyan embassy allegedly pressuring SA workers to test for HIV

Libyan embassy allegedly pressuring SA workers to test for HIV

The Department of International Relations and Cooperation is investigating allegations that South Africans working at the Libyan embassy in Pretoria were pressured to test and reveal their HIV status after asking to be tested for COVID-19.

Read More

SA to take part in two more COVID-19 vaccine trials

SA to take part in two more COVID-19 vaccine trials

South Africa is consolidating its place in the race for a COVID-19 vaccine with its participation starting from next month in two new international trials of vaccine candidates. Adele Baleta reports.

Read More

IN-DEPTH: Vaginal ring ushers in new era in HIV prevention

IN-DEPTH: Vaginal ring ushers in new era in HIV prevention

A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.

Read More

Breakthrough hepatitis C medicines remain in regulatory limbo

Breakthrough hepatitis C medicines remain in regulatory limbo

Over the last decade the treatment of hepatitis C, a virus that can infect and damage the liver, has been revolutionised by a new class of medicines called direct acting antivirals. Catherine Tomlinson investigates the regulatory obstacles that are limiting access to these breakthrough medicines in South Africa.

Read More

Op-ed: President Ramaphosa should support the COVID-19 IP pool

Op-ed: President Ramaphosa should support the COVID-19 IP pool

Having pressed the imperative of equitable global sharing of COVID-19 health products, President Ramaphosa must now declare support for the Intellectual Property Pool for COVID-19, argues Professor Yousuf Vawda & Professor Brook K Baker.

Read More